Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emanuele Zucca

Showing results (1-10 of 315) with videos related to

Pageof 32
Sort By:
Journal of the National Cancer Institute|October 5, 2006
Chlamydia or not Chlamydia, that is the question: which is the microorganism associated with MALT lymphomas of the ocular adnexa?Emanuele Zucca, Francesco Bertoni
Oncology (Williston Park, N.Y.)|May 4, 2007
Cutaneous T-cell lymphoma: from genetics to clinical practiceReinhard Dummer, Emanuele Zucca
Blood|March 19, 2016
The spectrum of MALT lymphoma at different sites: biological and therapeutic relevanceEmanuele Zucca, Francesco Bertoni
Blood|June 27, 2009
How I treat mantle cell lymphomaMichele Ghielmini, Emanuele Zucca
Best Practice & Research. Clinical Haematology|March 15, 2017
Clinical aspects and therapy of gastrointestinal MALT lymphomaCatherine Thieblemont, Emanuele Zucca
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2005
State-of-the-art therapeutics: marginal-zone lymphomaFrancesco Bertoni, Emanuele Zucca
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2005
Another Piece of the MALT Lymphomas JigsawEmanuele Zucca, Francesco Bertoni
Hematological Oncology|July 13, 2022
D<sub>max</sub> : A simple and reliable PET/CT-derived new biomarker of lymphoma outcome?Luca Ceriani, Emanuele Zucca
Current Hematology Reports|December 30, 2003
Are antibiotics the treatment of choice for gastric lymphoma?Emanuele Zucca, Franco Cavalli
Nature Clinical Practice. Oncology|July 9, 2008
Who should receive myeloablative therapy for diffuse large B-cell lymphoma?Luciano Wannesson, Emanuele Zucca
Pageof 32

Showing results (1-10 of 315) with videos related to

Sort By:
Pageof 32
Journal of the National Cancer Institute|October 5, 2006
Chlamydia or not Chlamydia, that is the question: which is the microorganism associated with MALT lymphomas of the ocular adnexa?Emanuele Zucca, Francesco Bertoni
Oncology (Williston Park, N.Y.)|May 4, 2007
Cutaneous T-cell lymphoma: from genetics to clinical practiceReinhard Dummer, Emanuele Zucca
Blood|March 19, 2016
The spectrum of MALT lymphoma at different sites: biological and therapeutic relevanceEmanuele Zucca, Francesco Bertoni
Blood|June 27, 2009
How I treat mantle cell lymphomaMichele Ghielmini, Emanuele Zucca
Best Practice & Research. Clinical Haematology|March 15, 2017
Clinical aspects and therapy of gastrointestinal MALT lymphomaCatherine Thieblemont, Emanuele Zucca
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2005
State-of-the-art therapeutics: marginal-zone lymphomaFrancesco Bertoni, Emanuele Zucca
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2005
Another Piece of the MALT Lymphomas JigsawEmanuele Zucca, Francesco Bertoni
Hematological Oncology|July 13, 2022
D<sub>max</sub> : A simple and reliable PET/CT-derived new biomarker of lymphoma outcome?Luca Ceriani, Emanuele Zucca
Current Hematology Reports|December 30, 2003
Are antibiotics the treatment of choice for gastric lymphoma?Emanuele Zucca, Franco Cavalli
Nature Clinical Practice. Oncology|July 9, 2008
Who should receive myeloablative therapy for diffuse large B-cell lymphoma?Luciano Wannesson, Emanuele Zucca
Pageof 32